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INTRODUCTION
Antibodies to antigens of the HLA system are formed by a proportion of
women during a pregnancy and sometimes after blood transfusion. The gesta-
tional antibodies are of no significance to the pregnancy and in most cases they
are thought to disappear from the serum a few weeks after termination of the
pregnancy. They are, however, of great value as HLA typing reagents and
most tissue typing laboratories (including our own) rely heavily on pregnancy
sera as their source of HLA antisera. Blood samples from many mothers during
their pregnancies are sent to the Northern Ireland Blood Transfusion Service
for red cell antibody screening and aliquots of these sera are also examined for
HLA antibodies. When a serum is found to contain a monospecific antibody
of potential value for tissue typing, the patient and/or her family doctor are
contacted and arrangements are made to take a further 50 ml sample of blood.
This serum is sufficient for our own needs but in order to facilitate the inter-
change of sera with other laboratories both in the United Kingdom and abroad
larger volumes of sera are necessary. It is inappropriate to ask for a full standard
donation of blood from a mother a short time before or after the end of a
pregnancy. Large volumes of serum can be obtained by plasmapheresis, a pro-
cedure which entails no loss of red cells by the patient, but because of the time
involved it is often inconvenient for the mother of a new baby to attend hospital
(or the transfusion service building) to give plasma by this means.
"We have therefore considered a different approach for obtaining large volume
supplies of HLA typing sera. In some women, HLA antibodies may persist for
years after pregnancy (Tongio, Berrebi and Mayer, 1973) and therefore a pro-
portion of female blood donors might be expected to have these persistent and
stable antibodies. It would not be difficult to obtain 'dry bottle' donations from
selected regular blood donors at their next visit to the transfusion centre.
With a view to obtaining HLA typing sera in this way we screened blood
samples from a group of female blood donors. This paper reports our findings.
MATERIALS AND METHODS
Blood samples (2 ml) were obtained from 7,230 female blood donors for HLA
antibody screening. To simplify administrative procedures no attempt was made
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and stored at -20°C for up to three weeks before screening against panels of
lymphocytes selected to include all the known HLA-A and -B locus antigens.
A standard two-stage microcytotoxicity test at 22°C was used throughout.
Sera showing HLA activity were, if necessary, further tested to identify
monospecific antibodies. A simple questionnaire was sent to the blood donors
found to have antibodies. In it we asked whether or not they had 'evt had a
blood transfusion and/or pregnancy and if so, the dates thereof.
RESULTS
Table 1 summarises our findings in the blood donors and compares them with
the results of routine screening of ante-natal sera. Of 220 pregnancy/transfusion
questionnaires issued 172 (78 per cent) were returned. The answers are sum-
marised in Tables 2 and 3.
TABLE 1: HLA ANTIBODIES PRESENT IN SERA FROM BLOOD DONORS AND
ANTE-NATAL SAMPLES
No. of samples tested
No. with HLA antibody
No. with monospecific antibody
Blood donors
7230
220 (3.04%)
25 (0.35%)
Ante-natal
4756
956 (20.1%)
44 (0.93%)
TABLE 2: SUMMARY OF REPLIES TO
History of Blood Transfusion
YES
NO
PREGNANCY/TRANSFUSION QUESTIONNAIRE
History of Pregnancy
Yes
34
120
154
No
0
18
18 172
TABLE 3: INTERVAL SINCE
Years
10+
5-10
2-5
0-2
Pregnant at time of sample
Reply unclear
LAST IMMUNISING
Pregnancy
Alone
31
25
41
13
3
7
STIMULUS
Pregnancy
and Transfusion
8
10
8
7
0
1
163DISCUSSION
The proportion of blood donors with HLA antibodies was, as expected, much
smaller than the proportion of ante-natal sera with anti HLA activity (3.04 per
cent as compared with 20.1 per cent). The yield might have been improved if we
had selected only blood donors who had been pregnant; our figures might then
have approached those of Rodey, Anderson and Aster, (1976) who found HLA
antibodies in 18.7 per cent of non-pregnant multiparae with a history of four or
more pregnancies.
The replies to our questionnaire indicated clearly that transfusion alone is not
a common stimulus to the production of persistent antibodies; and almost 90 per
cent of the blood donors with antibodies had been pregnant at some time. Their
antibodies are remarkably long lived: 74 of 154 women with antibodies (48.1 per
cent) had not been pregnant nor had transfusion for 5 or more years. In Rodey's
(1976) series the corresponding figure was 64 per cent, presumably due to the
greater (4 or more) parity of his donors.
We define an antibody to be potentially valuable for tissue typing if it is
adequately avid and if it appears to be monospecific. Ante-natal sera often con-
tain multispecific antibodies and only a small proportion (44 of 956 = 4.6 per
cent) are potential tissue typing sera. On the other hand, antibody containing
sera from blood donors yield a much higher proportion of "clean" HLA anti-
bodies (25 of 220 = 11.36 per cent) probably because the weaker and cross
reacting antibodies have declined in activity to undetectable levels.
Our finding of HLA antibodies in a significant number of female blood donors
Confirms the possibility of obtaining HLA typing sera from this source. The vast
majority of donors give blood regularly and it is a simple administrative matter
to arrange for the taking of "dry bottle" donations from specially identified
donors. As an alternative plasmapheresis could be considered although this
would often entail a special visit to the transfusion centre and we feel it important
to avoid, as far as possible, interference wilth the routines of blood donation and
collection. In order to reduce unproductive screening of negative sera, multi-
parous dopors could be chosen for testing and we feel that this particular group
represents a viable alternative to pregnant mothers as a source of typing sera,
especially for HLA laboratories located within transfusion centres.
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